5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Safety and Outcomes of Different Surgical Techniques for Cubital Tunnel Decompression : A Systematic Review and Network Meta-analysis

      research-article
      , MBBS, MSc, MClinEd 1 , 2 , , , MRes 1 , 2 , , MRes 1 , 2 , , MBBS, BSc 3 , 4 , , MBChB, BMedSci 5 , , MB, BCh 1 , 2
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          For adults with primary cubital tunnel syndrome, which operation is associated with the best chance of symptomatic cure and lowest risk of complications?

          Findings

          This network meta-analysis included 30 studies comparing 8 different operations in 2894 limbs. It found that 87% of patients improve with surgery and that open in situ decompression (with or without a medial epicondylectomy) was associated with the greatest response to treatment and lowest complication risk.

          Meaning

          The findings of this study suggest that for adults with primary cubital tunnel syndrome, the most beneficial operation appears to be open in situ decompression.

          Abstract

          This systematic review and network meta-analysis evaluates which operation for cubital tunnel syndrome is associated with the best chance of symptomatic cure and lowest risk of complications.

          Abstract

          Importance

          Cubital tunnel syndrome is the second most common compressive neuropathy, affecting 6% of the population. Numerous different operations are performed globally to treat it; however, prior conventional (pairwise) meta-analyses have been unable to determine which procedure is associated with the best outcomes and fewest complications.

          Objective

          To evaluate which operation for cubital tunnel syndrome is associated with the greatest likelihood of symptomatic cure.

          Data Sources

          PubMed, EMBASE, and CENTRAL were searched from database inception to March 2, 2019, with no restrictions on the setting or design of studies.

          Study Selection

          Experimental and observational studies directly comparing the outcomes of at least 2 surgical treatments for adults with primary cubital tunnel syndrome were included. Case reports were excluded, and when comparative studies had subgroups with 1 participant, the single-participant subgroup was excluded. The treatments had to be in situ decompression with or without medial epicondylectomy or an anterior subcutaneous, subfascial, intramuscular, or submuscular transposition. The access could be open, minimally invasive, or endoscopic. The comparator could be sham surgery or any operation mentioned earlier.

          Data Extraction and Synthesis

          Data were extracted by 2 independent reviewers, following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline and the PRISMA Network Meta-analysis extension statement. Network meta-analysis was used to estimate the relative efficacy and safety associated with interventions using relative risks. Surgical techniques were ranked by their probability of being the best (P score) and interpreted in terms of their clinical impact.

          Main Outcomes and Measures

          The primary outcome was response to treatment (ie, symptomatic improvement). The secondary outcomes were perioperative complications, reoperation, and recurrence.

          Results

          A total of 30 studies of 2894 limbs undergoing 8 different operations were included. Across the studies, 56% of participants were men, the mean (SD) age was 48 (8) years, and patients had symptoms for a mean (SD) of 15 (7) months. Overall, 87% (95% CI, 92%-91%) of patients improved with surgery; all forms of in situ decompression were more effective than any type of transposition procedure; for example, open in situ decompression with epicondylectomy was associated with higher success rates than subcutaneous transposition (relative risk, 1.13; 95% CI, 1.01-1.25). Postoperatively, 3% (95% CI, 2%-4%) of patients developed complications, and in situ decompressions were ranked as the least risky, although there was considerable uncertainty in this outcome. Overall, 2% (95% CI, 1%-3%) of patients required reoperation; open in situ decompression was associated with the fewest reoperations; in comparison, submuscular transposition was associated with 5 times the risk of reoperation (relative risk, 5.08; 95% CI, 2.06-12.52). During surveillance, 3% (95% CI, 1%-4%) of patients developed recurrence, and open in situ decompression with epicondylectomy was ranked as the safest operation, although there was uncertainty in the estimates.

          Conclusions and Relevance

          In this network meta-analysis, open in situ decompression (with or without medial epicondylectomy) appeared to be the safest operation and also was associated with the best outcomes for patients with primary cubital tunnel syndrome. Future research should focus on better defining this disorder and developing core outcome measures.

          Related collections

          Most cited references82

          • Record: found
          • Abstract: not found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

            Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Conducting Meta-Analyses inRwith themetaforPackage

                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                24 November 2020
                November 2020
                24 November 2020
                : 3
                : 11
                : e2024352
                Affiliations
                [1 ]Department of Plastic and Reconstructive Surgery, Leeds Teaching Hospitals Trust, Leeds, United Kingdom
                [2 ]Leeds Institute for Medical Research, University of Leeds, Leeds, United Kingdom
                [3 ]Cancer Epidemiology Group, Institute of Cancer and Pathology and Institute of Data Analytics, University of Leeds, United Kingdom
                [4 ]Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom
                [5 ]Bristol Institute of Clinical Neuroscience, Southmead Hospital, Bristol, United Kingdom
                Author notes
                Article Information
                Accepted for Publication: September 7, 2020.
                Published: November 24, 2020. doi:10.1001/jamanetworkopen.2020.24352
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Wade RG et al. JAMA Network Open.
                Corresponding Author: Ryckie G. Wade, MBBS, MSc, MClinEd, Academic Plastic Surgery Office, Department of Plastic and Reconstructive Surgery, Leeds General Infirmary, Leeds Teaching Hospitals, Leeds LS1 3EX, United Kingdom ( ryckiewade@ 123456gmail.com ).
                Author Contributions: Mr Wade and Ms Bourke had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Wade, Burr, Teo.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Wade, Griffiths, Flather.
                Critical revision of the manuscript for important intellectual content: Wade, Flather, Burr, Teo, Bourke.
                Statistical analysis: Wade, Burr.
                Obtained funding: Wade.
                Administrative, technical, or material support: Wade, Griffiths, Flather.
                Supervision: Wade, Teo, Bourke.
                Conflict of Interest Disclosures: Mr Wade reported receiving grants from the National Institute for Health Research (NIHR) during the conduct of the study and from NIHR outside the submitted work. Dr Burr reported receiving personal fees from Takeda and AbbVie outside the submitted work. No other disclosures were reported.
                Funding/Support: Mr Wade is a doctoral research fellow funded by the NIHR (DRF-2018-11-ST2-028).
                Role of the Funder/Sponsor: The NIHR had no direct role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: The views expressed are those of the author(s) and not necessarily those of the United Kingdom’s National Health Service, NIHR, or Department of Health.
                Additional Contributions: We thank Hebatullah M. Abdulazeem, PGDip (Technische Universität München), and Shenxing Du (Dongyang People’s Hospital/The Affiliated Dongyang Hospital of Wenzhou Medical University) for translating articles originally written in German and Chinese, respectively. We thank Orestis Efthimiou, PhD (Institute of Social and Preventive Medicine, University of Bern), for providing the basis of the regimens in R for combining randomized and nonrandomized evidence. We thank Alexis Dinno, ScD, MPH, MEM (Portland State University), for her advice on the ideal method of adjustment for multiplicity when assessing our transitivity assumptions, using her dunntest package within Stata. No one received financial compensation for their contributions.
                Additional Information: The raw extracted data are available via the Open Science Framework at https://osf.io/8kyw7/. The statistical syntax is available from Mr Wade on request.
                Article
                zoi200800
                10.1001/jamanetworkopen.2020.24352
                7686867
                33231636
                37046bc9-c30d-4de7-806b-aed57b0808ee
                Copyright 2020 Wade RG et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 21 May 2020
                : 7 September 2020
                Categories
                Research
                Original Investigation
                Online Only
                Surgery

                Comments

                Comment on this article